Invasive lobular carcinoma (ILC), a less common but increasingly prevalent form of breast cancer, is raising concerns among medical professionals worldwide. Recent studies show that ILC is growing in incidence at a faster rate than many other types of breast cancer.
Unlike the more familiar invasive ductal carcinoma, ILC begins in the milk-producing glands (lobules) of the breast. Its subtle symptoms often make early detection difficult, as it may not form a distinct lump detectable by routine screening.
Experts stress the importance of regular screenings, particularly for individuals with a family history of breast cancer. Modern imaging technologies and biopsy techniques have improved the early detection of ILC, allowing timely treatment and better patient outcomes.
Research into the causes, progression, and treatment of ILC is ongoing, as healthcare providers aim to increase awareness and improve survival rates. Early diagnosis remains critical in managing this challenging type of cancer.
Source: Thepressradio.com
